Myeloid
AML with Maturation
AML with Recurrent Genetic Abnormalities
MDS with Multilineage Dysplasia
MDS with Ring Sideroblasts
Essential Thrombocythemia
Disseminated Juvenile Xanthogranuloma
Systemic Mastocytosis with an Associated Hematological Neoplasm
Therapy-Related Myelodysplastic Syndrome
AML (megakaryoblastic) with t(1;22)(p13.3;q13.3);RBM15-MKL1
Histiocytic Sarcoma
Myeloid Benign
MDS/MPN with Ring Sideroblasts and Thrombocytosis
Myelodysplastic Workup
MDS with Ring Sideroblasts and Multilineage Dysplasia
MDS with Isolated Del(5q)
Atypical Chronic Myeloid Leukemia, BCR-ABL1-
AML with t(6;9)(p23;q34.1);DEK-NUP214
Mastocytosis
AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22);CBFB-MYH11
Acute Leukemias of Ambiguous Lineage
Follicular Dendritic Cell Sarcoma
Myelodysplastic Syndromes
Myeloid Sarcoma
Smoldering Systemic Mastocytosis
Neoplastic Vs Reactive
Mixed Phenotype Acute Leukemia, T/Myeloid, NOS
Polycythemia Vera
Chronic Myelomonocytic Leukemia-0
Acute Panmyelosis with Myelofibrosis
Chronic Myelomonocytic Leukemia-1
Chronic Myelomonocytic Leukemia-2
MDS, Unclassifiable
Primary Myelofibrosis,Overt Fibrotic Stage
Polycythaemia Vera Myelofibrosis
Histiocytic and Dendritic Cell Neoplasms
Systemic Mastocytosis
Mixed Phenotype Acute Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
AML with Biallelic Mutations of CEBPA
Essential Thrombocythemia Myelofibrosis
Pure Erythroid Leukemia
Myeloid Neoplasm
AML with Myelodysplasia-Related Changes
Myeloproliferative Neoplasms
AML with BCR-ABL1
Xanthogranuloma
Myeloproliferative Workup
MDS with excess blasts-1
MDS with excess blasts-2
Erdheim-Chester Disease
Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement
Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement
Transient Abnormal Myelopoiesis
AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM
MDS/MPN, Unclassifiable
Myeloid/Lymphoid Neoplasms with PCM1-JAK2
Mixed Phenotype Acute Leukemia with t(v;11q23.3); KMT2A Rearranged
Chronic Eosinophilic Leukemia, NOS
AML with Variant RARA translocation
Acute Basophilic Leukemia
Rosai-Dorfman Disease
Indolent Systemic Mastocytosis
Mast Cell Leukemia
AML with Minimal Differentiation
Mixed Phenotype Acute Leukemia, B/Myeloid, NOS
Refractory Cytopenia of Childhood
Therapy-Related Acute Myeloid Leukemia
Therapy-Related Myeloid Neoplasms
APL with PML-RARA
MDS with Ring Sideroblasts and Single Lineage Dysplasia
Chronic Myelogenous Leukemia
Chronic Neutrophilic Leukemia
Chronic Myeloid Leukemia, BCR-ABL1+
Acute Myeloid Leukemia
Langerhans Cell Histiocytosis
Langerhans Cell Sarcoma
Primary Myelofibrosis
Myelodysplastic/Myeloproliferative Neoplasms
Juvenile Myelomonocytic Leukemia
Fibroblastic Reticular Cell Tumor
Mast Cell Sarcoma
AML with Mutated NPM1
Cutaneous Mastocytosis
AML, NOS
Aggressive Systemic Mastocytosis
Myeloproliferative Neoplasms, Unclassifiable
Acute Megakaryoblastic Leukemia
Primary Myelofibrosis, Prefibrotic/Early Stage
Acute Undifferentiated Leukemia
MDS with Single Lineage Dysplasia
Myeloid Neoplasms with Germ Line Predisposition
Acute Myelomonocytic Leukemia
AML without Maturation
Interdigitating Dendritic Cell Sarcoma
Indeterminate Dendritic Cell Tumor
Myeloid Leukemia Associated with Down Syndrome
Acute Monoblastic/Monocytic Leukemia
AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1
Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2
AML with Mutated RUNX1
MDS with Excess Blasts
Blastic Plasmacytoid Dendritic Cell Neoplasm
Myeloid Atypical
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
Chronic Myelomonocytic Leukemia
Myeloid Proliferations Related to Down Syndrome
AML with t(9;11)(p21.3;q23.3);MLLT3-KMT2A
